|
Phenotype
|
Fish
|
Conditions
|
Figures
|
|
kidney leukocyte infiltrative, abnormal
|
jak3mdu9/mdu9
|
standard conditions
|
Figure 5
from Basheer et al., 2022
|
|
blood lymphocyte decreased amount, abnormal
|
jak3mdu9/mdu9
|
standard conditions
|
Figure 4
from Basheer et al., 2022
|
|
kidney neoplastic, invasive, abnormal
|
jak3mdu9/mdu9
|
standard conditions
|
Figure 5
from Basheer et al., 2022
|
|
kidney nkl.4 expression decreased amount, abnormal
|
jak3mdu9/mdu9
|
standard conditions
|
Figure 4
from Basheer et al., 2022
|
|
whole organism cd8a expression decreased amount, abnormal
|
jak3mdu9/mdu9
|
standard conditions
|
Figure 3
from Basheer et al., 2022
|
|
kidney mpx expression decreased amount, abnormal
|
jak3mdu9/mdu9
|
standard conditions
|
Figure 4
from Basheer et al., 2022
|
|
thymus trac expression decreased distribution, abnormal
|
jak3mdu9/mdu9
|
standard conditions
|
Figure 2
from Basheer et al., 2022
|
|
brain leukocyte infiltrative, abnormal
|
jak3mdu9/mdu9
|
standard conditions
|
Figure 5
from Basheer et al., 2022
|
|
whole organism ighv1-1 expression absent, abnormal
|
jak3mdu9/mdu9
|
standard conditions
|
Fig. S2,
Figure 3
from Basheer et al., 2022
|
|
thymus rag1 expression decreased amount, abnormal
|
jak3mdu9/mdu9
|
standard conditions
|
Figure 2
from Basheer et al., 2022
|
|
kidney ighm expression decreased amount, abnormal
|
jak3mdu9/mdu9
|
standard conditions
|
Figure 4
from Basheer et al., 2022
|
|
kidney lmo2 expression decreased amount, abnormal
|
jak3mdu9/mdu9
|
standard conditions
|
Figure 4
from Basheer et al., 2022
|
|
intestine neoplastic, invasive, abnormal
|
jak3mdu9/mdu9
|
standard conditions
|
Figure 5
from Basheer et al., 2022
|
|
kidney ighd expression decreased amount, abnormal
|
jak3mdu9/mdu9
|
standard conditions
|
Figure 4
from Basheer et al., 2022
|
|
brain neoplastic, invasive, abnormal
|
jak3mdu9/mdu9
|
standard conditions
|
Figure 5
from Basheer et al., 2022
|
|
whole organism cd4-1 expression decreased amount, abnormal
|
jak3mdu9/mdu9
|
standard conditions
|
Figure 3
from Basheer et al., 2022
|
|
thymus trac expression decreased amount, abnormal
|
jak3mdu9/mdu9
|
standard conditions
|
Figure 2
from Basheer et al., 2022
|
|
kidney cd8a expression decreased amount, abnormal
|
jak3mdu9/mdu9
|
standard conditions
|
Figure 4
from Basheer et al., 2022
|
|
whole organism ighv4-6 expression absent, abnormal
|
jak3mdu9/mdu9
|
standard conditions
|
Fig. S2
from Basheer et al., 2022
|
|
kidney myeloid cell decreased amount, abnormal
|
jak3mdu9/mdu9
|
standard conditions
|
Figure 4
from Basheer et al., 2022
|
|
thymus rag1 expression decreased distribution, abnormal
|
jak3mdu9/mdu9
|
standard conditions
|
Figure 2
from Basheer et al., 2022
|
|
blood neutrophil increased amount, abnormal
|
jak3mdu9/mdu9
|
standard conditions
|
Figure 4
from Basheer et al., 2022
|
|
liver leukocyte infiltrative, abnormal
|
jak3mdu9/mdu9
|
standard conditions
|
Figure 5
from Basheer et al., 2022
|
|
liver neoplastic, invasive, abnormal
|
jak3mdu9/mdu9
|
standard conditions
|
Figure 5
from Basheer et al., 2022
|
|
kidney trac expression decreased amount, abnormal
|
jak3mdu9/mdu9
|
standard conditions
|
Figure 4
from Basheer et al., 2022
|
|
kidney cd4-1 expression decreased amount, abnormal
|
jak3mdu9/mdu9
|
standard conditions
|
Figure 4
from Basheer et al., 2022
|
|
thymus ikzf1 expression decreased distribution, abnormal
|
jak3mdu9/mdu9
|
standard conditions
|
Figure 2
from Basheer et al., 2022
|
|
thymus ikzf1 expression decreased amount, abnormal
|
jak3mdu9/mdu9
|
standard conditions
|
Figure 2
from Basheer et al., 2022
|
|
intestine leukocyte infiltrative, abnormal
|
jak3mdu9/mdu9
|
standard conditions
|
Figure 5
from Basheer et al., 2022
|
|
kidney nccrp1 expression decreased amount, abnormal
|
jak3mdu9/mdu9
|
standard conditions
|
Figure 4
from Basheer et al., 2022
|
|
thymus rag1 expression decreased distribution, abnormal
|
jak3mdu10/mdu10
|
standard conditions
|
Fig. S2
from Basheer et al., 2022
|
|
whole organism semi-lethal (sensu genetics), abnormal
|
jak3zf3747/zf3747
|
standard conditions
|
Fig. 3
from Basheer et al., 2022
|
|
kidney hematopoietic stem cell increased amount, abnormal
|
jak3zf3747/zf3747
|
standard conditions
|
Fig. 3
from Basheer et al., 2022
|
|
whole organism cd4-1 expression increased amount, abnormal
|
jak3zf3747/zf3747
|
control
|
Fig. 3
from Basheer et al., 2022
|
|
thymus rag1 expression increased amount, abnormal
|
jak3zf3747/zf3747
|
control
|
Fig. 2 ,
Fig. 4
from Basheer et al., 2022
|
|
lymphocyte increased amount, abnormal
|
jak3zf3747/zf3747
|
standard conditions
|
Fig. 2
from Basheer et al., 2022
|
|
kidney lymphocyte increased amount, abnormal
|
jak3zf3747/zf3747
|
standard conditions
|
Fig. 3
from Basheer et al., 2022
|
|
blood lymphocyte increased amount, abnormal
|
jak3zf3747/zf3747
|
standard conditions
|
Fig. 3
from Basheer et al., 2022
|
|
whole organism trac expression increased amount, abnormal
|
jak3zf3747/zf3747
|
control
|
Fig. 3
from Basheer et al., 2022
|
|
whole organism nccrp1 expression increased amount, abnormal
|
jak3zf3747/zf3747
|
control
|
Fig. 3
from Basheer et al., 2022
|
|
whole organism cd8a expression increased amount, abnormal
|
jak3zf3747/zf3747
|
control
|
Fig. 3
from Basheer et al., 2022
|
|
thymus lck expression increased amount, abnormal
|
jak3zf3747/zf3747
|
control
|
Fig. 2
from Basheer et al., 2022
|
|
whole organism nkl.4 expression increased amount, abnormal
|
jak3zf3747/zf3747
|
control
|
Fig. 3
from Basheer et al., 2022
|
|
whole organism rag1 expression increased amount, abnormal
|
jak3zf3747/zf3747
|
control
|
Fig. 3
from Basheer et al., 2022
|
|
thymus trac expression increased amount, abnormal
|
jak3zf3747/zf3747
|
control
|
Fig. 2
from Basheer et al., 2022
|
|
thymus ikzf1 expression increased amount, abnormal
|
jak3zf3747/zf3747
|
control
|
Fig. 2
from Basheer et al., 2022
|
|
kidney hematopoietic stem cell increased amount, abnormal
|
jak3zf3747/+
|
standard conditions
|
Fig. 3
from Basheer et al., 2022
|
|
thymus rag1 expression increased amount, abnormal
|
jak3zf3747/+
|
control
|
Fig. 2 ,
Fig. 4
from Basheer et al., 2022
|
|
lymphocyte increased amount, abnormal
|
jak3zf3747/+
|
standard conditions
|
Fig. 2
from Basheer et al., 2022
|
|
kidney lymphocyte increased amount, abnormal
|
jak3zf3747/+
|
standard conditions
|
Fig. 3
from Basheer et al., 2022
|
|
blood lymphocyte increased amount, abnormal
|
jak3zf3747/+
|
standard conditions
|
Fig. 3
from Basheer et al., 2022
|
|
thymus lck expression increased amount, abnormal
|
jak3zf3747/+
|
control
|
Fig. 2
from Basheer et al., 2022
|
|
whole organism cd8a expression increased amount, abnormal
|
jak3zf3747/+
|
control
|
Fig. 3
from Basheer et al., 2022
|
|
whole organism nccrp1 expression increased amount, abnormal
|
jak3zf3747/+
|
control
|
Fig. 3
from Basheer et al., 2022
|
|
thymus trac expression increased amount, abnormal
|
jak3zf3747/+
|
control
|
Fig. 2
from Basheer et al., 2022
|
|
thymus ikzf1 expression increased amount, abnormal
|
jak3zf3747/+
|
control
|
Fig. 2
from Basheer et al., 2022
|
|
whole organism rag1 expression increased amount, abnormal
|
jak3zf3747/+
|
control
|
Fig. 3
from Basheer et al., 2022
|
|
thymus rag1 expression decreased amount, abnormal
|
il2rgamdu2/mdu2; jak3zf3747/+
|
control
|
Fig. 4
from Basheer et al., 2022
|
|
thymus rag1 expression decreased amount, abnormal
|
il2rgamdu2/mdu2; jak3zf3747/zf3747
|
control
|
Fig. 4
from Basheer et al., 2022
|
|
thymus rag1 expression decreased amount, abnormal
|
jak3zf3747/+; jak1zf3761/zf3761
|
control
|
Fig. 4
from Basheer et al., 2022
|
|
thymus rag1 expression decreased amount, abnormal
|
jak3zf3747/zf3747; jak1zf3761/zf3761
|
control
|
Fig. 4
from Basheer et al., 2022
|